ArticleJournal of imaging2026
Erasing and Refining Discriminative Features for CNV Subtype Classification in OCT Images.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Choroidal neovascularization (CNV) subtype classification from optical coherence tomography (OCT) images is clinically important because treatment response and disease prognosis vary across subtypes. However, automated classification remains challenging owing to subtle inter-class differences and considerable imaging noise. We propose an erasing-refining discriminative feature network (ERDF-Net) that mitigates noisy dominant activations and reveals fine-grained structural cues. The model perturbs salient regions to facilitate subtle feature learning, restores clean salient information, and fuses both representations via channel-spatial attention to form a coherent and discriminative embedding of CNV morphology. Experiments on a clinical OCT dataset show that ERDF-Net consistently surpasses state-of-the-art fine-grained and erasing-based methods across multiple metrics. Ablation and visualization analyses further confirm the benefit and interpretability of controlled salient suppression and refined feature fusion. ERDF-Net provides an effective and reliable solution for fine-grained medical image classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.